Sabarubicin
Sabarubicin (MEN-10755), a disaccharide analog of doxorubicin, is used for the treatment of small cell lung cancer (SCLC).[1] It has been seen to show superior antitumour efficacy, which is purported to be linked to the activation of p53-independent apoptosis.[2]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C32H37NO13 |
Molar mass | 643.642 g·mol−1 |
3D model (JSmol) | |
| |
|
References
- http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2009/10/WC500005793.pdf
- Topics in Current Chemistry. 2008. 283. 171-189.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.